Latest Strides Pharma Science stock price

Strides Pharma Science P/E Ratio

STAR • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
21.99
Moderate Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 21.99
Current Price ₹968.00
EPS (TTM) ₹390.55
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 22.54
Historical Range 1.52 - 41.26
Percentile 50.0%

Sector Context

Sector Average 57.73
Sector Median 36.22
Sector Rank #11 of 88
Sector Percentile 12.5%

Earnings Breakdown (TTM)

TTM EPS ₹41.38
Sept 2025 ₹13.84
Mar 2025 ₹8.92

Key P/E Ratio Insights for Strides Pharma Science

  • Trading at discount to sector average PE of 57.73

View the STAR equity price for detailed stock performance.

P/E Ratio Historical Trend for Strides Pharma Science

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 1.52 383.99 ₹584.55 NSE Low
2019 12.96 32.14 ₹416.50 NSE Low
2017 41.26 23.14 ₹954.65 NSE High
2016 34.4 33.9 ₹1166.30 NSE High

Sector P/E Ratio Comparison

Comparing Strides Pharma Science with other companies in Healthcare sector
Sector Average
57.73
Sector Median
36.22
Lowest P/E
9.01
Highest P/E
515.32
Companies
88
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low
Lincoln Pharmaceuticals LINCOLN 12.02 ₹974 Low
QMS Medical Allied Servi… QMSMEDI 12.82 ₹177 Low
Take Solutions TAKE 13.15 ₹638 Low
Venus Remedies VENUSREM 14.27 ₹995 Low
Royal Sense ROYAL 14.5 ₹96 Low
Bliss GVS Pharma BLISSGVS 16.62 ₹1,973 Moderate
RPG Life Sciences RPGLIFE 17.94 ₹3,861 Moderate